Cite

HARVARD Citation

    Kearsley-Fleet, L. et al. (2019). Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. Rheumatology. pp. 94-102. [Online]. 
  
Back to record